Selected research
Market Structure
Global Hyperthermia Cancer Treatment Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Hyperthermia Cancer Treatment Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Hyperthermia Cancer Treatment Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hyperthermia Cancer Treatment Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hyperthermia Cancer Treatment Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Hyperthermia Cancer Treatment Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hyperthermia Cancer Treatment Devices include Pyrexar Medical, Oncotherm, Andromedic, Yamamoto Vinita, Med-Logix, Thermofield, Celsius42, Dongseo Medicare and ThermaSolutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Hyperthermia Cancer Treatment Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hyperthermia Cancer Treatment Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hyperthermia Cancer Treatment Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hyperthermia Cancer Treatment Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Hyperthermia Cancer Treatment Devices Segment by Company
Pyrexar Medical
Oncotherm
Andromedic
Yamamoto Vinita
Med-Logix
Thermofield
Celsius42
Dongseo Medicare
ThermaSolutions
Verthermia
Combat Medical
Hydrosun
RanD Biotech
Shenzhen ET Medical Technology
Jiangsu Nova Medical Equipment
Hyperthermia Cancer Treatment Devices Segment by Type
Superficial Hyperthermia
Deep Regional Hyperthermia
Hyperthermia Cancer Treatment Devices Segment by Application
Breast Cancer
Cervical Cancer
Soft Tissue Sarcoma
Melanoma
Others
Hyperthermia Cancer Treatment Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperthermia Cancer Treatment Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyperthermia Cancer Treatment Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperthermia Cancer Treatment Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hyperthermia Cancer Treatment Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hyperthermia Cancer Treatment Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyperthermia Cancer Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hyperthermia Cancer Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Superficial Hyperthermia
- Deep Regional Hyperthermia
Applications
- Breast Cancer
- Cervical Cancer
- Soft Tissue Sarcoma
- Melanoma
- Others
Companies covered
- Pyrexar Medical
- Oncotherm
- Andromedic
- Yamamoto Vinita
- Med-Logix
- Thermofield
- Celsius42
- Dongseo Medicare
- ThermaSolutions
- Verthermia
- Combat Medical
- Hydrosun
- RanD Biotech
- Shenzhen ET Medical Technology
- Jiangsu Nova Medical Equipment
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hyperthermia Cancer Treatment Devices Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hyperthermia Cancer Treatment Devices Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Hyperthermia Cancer Treatment Devices Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Hyperthermia Cancer Treatment Devices Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Hyperthermia Cancer Treatment Devices Market Dynamics
- 2.1 Hyperthermia Cancer Treatment Devices Industry Trends
- 2.2 Hyperthermia Cancer Treatment Devices Industry Drivers
- 2.3 Hyperthermia Cancer Treatment Devices Industry Opportunities and Challenges
- 2.4 Hyperthermia Cancer Treatment Devices Industry Restraints
3 Hyperthermia Cancer Treatment Devices Market by Manufacturers
- 3.1 Global Hyperthermia Cancer Treatment Devices Revenue by Manufacturers (2021-2026)
- 3.2 Global Hyperthermia Cancer Treatment Devices Sales by Manufacturers (2021-2026)
- 3.3 Global Hyperthermia Cancer Treatment Devices Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Hyperthermia Cancer Treatment Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hyperthermia Cancer Treatment Devices Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hyperthermia Cancer Treatment Devices Manufacturers, Product Type & Application
- 3.7 Global Hyperthermia Cancer Treatment Devices Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hyperthermia Cancer Treatment Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hyperthermia Cancer Treatment Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Hyperthermia Cancer Treatment Devices Tier 1, Tier 2, and Tier 3
4 Hyperthermia Cancer Treatment Devices Market by Type
- 4.1 Hyperthermia Cancer Treatment Devices Type Introduction
- 4.1.1 Superficial Hyperthermia
- 4.1.2 Deep Regional Hyperthermia
- 4.2 Global Hyperthermia Cancer Treatment Devices Sales by Type
- 4.2.1 Global Hyperthermia Cancer Treatment Devices Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hyperthermia Cancer Treatment Devices Sales by Type (2021-2032)
- 4.2.3 Global Hyperthermia Cancer Treatment Devices Sales Market Share by Type (2021-2032)
- 4.3 Global Hyperthermia Cancer Treatment Devices Revenue by Type
- 4.3.1 Global Hyperthermia Cancer Treatment Devices Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hyperthermia Cancer Treatment Devices Revenue by Type (2021-2032)
- 4.3.3 Global Hyperthermia Cancer Treatment Devices Revenue Market Share by Type (2021-2032)
5 Hyperthermia Cancer Treatment Devices Market by Application
- 5.1 Hyperthermia Cancer Treatment Devices Application Introduction
- 5.1.1 Breast Cancer
- 5.1.2 Cervical Cancer
- 5.1.3 Soft Tissue Sarcoma
- 5.1.4 Melanoma
- 5.1.5 Others
- 5.2 Global Hyperthermia Cancer Treatment Devices Sales by Application
- 5.2.1 Global Hyperthermia Cancer Treatment Devices Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hyperthermia Cancer Treatment Devices Sales by Application (2021-2032)
- 5.2.3 Global Hyperthermia Cancer Treatment Devices Sales Market Share by Application (2021-2032)
- 5.3 Global Hyperthermia Cancer Treatment Devices Revenue by Application
- 5.3.1 Global Hyperthermia Cancer Treatment Devices Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hyperthermia Cancer Treatment Devices Revenue by Application (2021-2032)
- 5.3.3 Global Hyperthermia Cancer Treatment Devices Revenue Market Share by Application (2021-2032)
6 Global Hyperthermia Cancer Treatment Devices Sales by Region
- 6.1 Global Hyperthermia Cancer Treatment Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hyperthermia Cancer Treatment Devices Sales by Region (2021-2032)
- 6.2.1 Global Hyperthermia Cancer Treatment Devices Sales by Region (2021-2026)
- 6.2.2 Global Hyperthermia Cancer Treatment Devices Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hyperthermia Cancer Treatment Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hyperthermia Cancer Treatment Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hyperthermia Cancer Treatment Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hyperthermia Cancer Treatment Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Hyperthermia Cancer Treatment Devices Revenue by Region
- 7.1 Global Hyperthermia Cancer Treatment Devices Revenue by Region
- 7.1.1 Global Hyperthermia Cancer Treatment Devices Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Hyperthermia Cancer Treatment Devices Revenue by Region (2021-2026)
- 7.1.3 Global Hyperthermia Cancer Treatment Devices Revenue by Region (2027-2032)
- 7.1.4 Global Hyperthermia Cancer Treatment Devices Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Hyperthermia Cancer Treatment Devices Revenue (2021-2032)
- 7.2.2 North America Hyperthermia Cancer Treatment Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Hyperthermia Cancer Treatment Devices Revenue (2021-2032)
- 7.3.2 Europe Hyperthermia Cancer Treatment Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hyperthermia Cancer Treatment Devices Revenue (2021-2032)
- 7.4.2 Asia-Pacific Hyperthermia Cancer Treatment Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hyperthermia Cancer Treatment Devices Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Hyperthermia Cancer Treatment Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pyrexar Medical
- 8.1.1 Pyrexar Medical Company Information
- 8.1.2 Pyrexar Medical Business Overview
- 8.1.3 Pyrexar Medical Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pyrexar Medical Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.1.5 Pyrexar Medical Recent Developments
- 8.2 Oncotherm
- 8.2.1 Oncotherm Company Information
- 8.2.2 Oncotherm Business Overview
- 8.2.3 Oncotherm Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Oncotherm Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.2.5 Oncotherm Recent Developments
- 8.3 Andromedic
- 8.3.1 Andromedic Company Information
- 8.3.2 Andromedic Business Overview
- 8.3.3 Andromedic Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Andromedic Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.3.5 Andromedic Recent Developments
- 8.4 Yamamoto Vinita
- 8.4.1 Yamamoto Vinita Company Information
- 8.4.2 Yamamoto Vinita Business Overview
- 8.4.3 Yamamoto Vinita Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Yamamoto Vinita Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.4.5 Yamamoto Vinita Recent Developments
- 8.5 Med-Logix
- 8.5.1 Med-Logix Company Information
- 8.5.2 Med-Logix Business Overview
- 8.5.3 Med-Logix Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Med-Logix Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.5.5 Med-Logix Recent Developments
- 8.6 Thermofield
- 8.6.1 Thermofield Company Information
- 8.6.2 Thermofield Business Overview
- 8.6.3 Thermofield Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Thermofield Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.6.5 Thermofield Recent Developments
- 8.7 Celsius42
- 8.7.1 Celsius42 Company Information
- 8.7.2 Celsius42 Business Overview
- 8.7.3 Celsius42 Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Celsius42 Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.7.5 Celsius42 Recent Developments
- 8.8 Dongseo Medicare
- 8.8.1 Dongseo Medicare Company Information
- 8.8.2 Dongseo Medicare Business Overview
- 8.8.3 Dongseo Medicare Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Dongseo Medicare Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.8.5 Dongseo Medicare Recent Developments
- 8.9 ThermaSolutions
- 8.9.1 ThermaSolutions Company Information
- 8.9.2 ThermaSolutions Business Overview
- 8.9.3 ThermaSolutions Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 ThermaSolutions Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.9.5 ThermaSolutions Recent Developments
- 8.10 Verthermia
- 8.10.1 Verthermia Company Information
- 8.10.2 Verthermia Business Overview
- 8.10.3 Verthermia Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Verthermia Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.10.5 Verthermia Recent Developments
- 8.11 Combat Medical
- 8.11.1 Combat Medical Company Information
- 8.11.2 Combat Medical Business Overview
- 8.11.3 Combat Medical Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Combat Medical Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.11.5 Combat Medical Recent Developments
- 8.12 Hydrosun
- 8.12.1 Hydrosun Company Information
- 8.12.2 Hydrosun Business Overview
- 8.12.3 Hydrosun Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Hydrosun Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.12.5 Hydrosun Recent Developments
- 8.13 RanD Biotech
- 8.13.1 RanD Biotech Company Information
- 8.13.2 RanD Biotech Business Overview
- 8.13.3 RanD Biotech Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 RanD Biotech Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.13.5 RanD Biotech Recent Developments
- 8.14 Shenzhen ET Medical Technology
- 8.14.1 Shenzhen ET Medical Technology Company Information
- 8.14.2 Shenzhen ET Medical Technology Business Overview
- 8.14.3 Shenzhen ET Medical Technology Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Shenzhen ET Medical Technology Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.14.5 Shenzhen ET Medical Technology Recent Developments
- 8.15 Jiangsu Nova Medical Equipment
- 8.15.1 Jiangsu Nova Medical Equipment Company Information
- 8.15.2 Jiangsu Nova Medical Equipment Business Overview
- 8.15.3 Jiangsu Nova Medical Equipment Hyperthermia Cancer Treatment Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Jiangsu Nova Medical Equipment Hyperthermia Cancer Treatment Devices Product Portfolio
- 8.15.5 Jiangsu Nova Medical Equipment Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hyperthermia Cancer Treatment Devices Value Chain Analysis
- 9.1.1 Hyperthermia Cancer Treatment Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hyperthermia Cancer Treatment Devices Production Mode & Process
- 9.2 Hyperthermia Cancer Treatment Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hyperthermia Cancer Treatment Devices Distributors
- 9.2.3 Hyperthermia Cancer Treatment Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst